Welcome to our dedicated page for Convey Health Solutions Hldgs news (Ticker: CNVY), a resource for investors and traders seeking the latest updates and insights on Convey Health Solutions Hldgs stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Convey Health Solutions Hldgs's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Convey Health Solutions Hldgs's position in the market.
Convey Holding Parent, Inc. (NYSE: CNVY) has successfully completed its initial public offering, selling 13,333,334 shares at $14.00 each. The offering consisted of 11,666,667 shares sold by the company and 1,666,667 shares by a selling stockholder. Additionally, underwriters have a 30-day option to buy up to 2,000,000 additional shares. The registration statement for this sale was declared effective on June 15, 2021. BofA Securities, Goldman Sachs, and J.P. Morgan were the lead underwriters for this offering.
Convey Holding Parent, Inc. has announced the pricing of its initial public offering (IPO) of 13,333,334 shares at $14.00 each, with the offering expected to close on June 18, 2021. The IPO includes 11,666,667 shares from the company and 1,666,667 from a selling stockholder. The underwriters hold a 30-day option for 2,000,000 additional shares. The company's stock will begin trading on the NYSE under the ticker symbol 'CNVY' on June 16, 2021. Proceeds will be used to repay existing debt and for general corporate purposes.
Convey Health announced the launch of its initial public offering (IPO) of 13,333,334 shares of common stock, aiming to offer 11,666,667 shares by the company and 1,666,667 shares from a selling stockholder. The IPO price is estimated between $14.00 and $16.00 per share, with an option for underwriters to purchase an additional 2,000,000 shares. Proceeds will be used to repay existing debt and for general corporate purposes. Convey Health seeks to list on the New York Stock Exchange under the ticker CNVY.